e.g. Tata motors, Reliance MF, 500570

Jenburkt Pharmaceuticals Ltd. - Research Center

524731 JENBURPH Group (X) BSE data
 
Back to Company Page
Statement:

Profit loss account

(Rs crore)
Mar ' 25 Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21
Income
Operating income 151.69 141.97 136.75 123.98 109.29
Expenses
Material consumed 29.66 30.41 33.00 31.43 30.10
Manufacturing expenses 1.86 1.47 1.56 1.24 0.84
Personnel expenses 45.54 42.49 38.81 36.49 32.38
Selling expenses - - - - -
Adminstrative expenses 34.24 34.47 33.01 27.56 26.13
Expenses capitalised - - - - -
Cost of sales 111.30 108.85 106.38 96.73 89.45
Operating profit 40.39 33.12 30.37 27.26 19.84
Other recurring income 6.72 4.67 5.12 4.95 4.31
Adjusted PBDIT 47.11 37.79 35.49 32.20 24.15
Financial expenses 0.45 0.27 0.37 0.43 0.47
Depreciation 2.73 2.34 2.26 1.90 2.04
Other write offs - - - - -
Adjusted PBT 43.93 35.18 32.86 29.87 21.64
Tax charges 11.87 9.20 8.26 7.57 5.14
Adjusted PAT 32.06 25.98 24.61 22.30 16.50
Non recurring items 2.92 1.39 -0.01 - -
Other non cash adjustments - - - - -
Reported net profit 34.98 27.37 24.60 22.30 16.50
Earnigs before appropriation 169.09 140.47 133.13 113.21 90.91
Equity dividend 6.75 6.36 5.51 4.68 -
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 162.34 134.12 127.62 108.53 90.91
Close
Add Jenburkt Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Jenburkt Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback